- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.04. | India sees insignificant revision to price ceiling in 2024 | ||
| 16.04. | Norgine seeks approval for high-risk neuroblastoma treatment | ||
| 16.04. | Sanofi signs mRNA vaccine development deal with IDT Australia | ||
| 15.04. | Marinus fails to meet early stopping criteria for status epilepticus trial | ||
| 15.04. | Soligenix bags orpan drug designation for Marburg virus vaccine | ||
| 15.04. | Portage mulls company closure, pauses enrolment for lead clinical programme | ||
| 15.04. | Sanofi advances NK cell engager to Phase II for blood cancer treatment | ||
| 15.04. | Pharmaceutical packaging companies, materials, and containment services for the pharmaceutical industry | ||
| 15.04. | Commercial dose companies in contract manufacturing | ||
| 15.04. | Cloud computing in the pharmaceutical industry | ||
| 15.04. | Glenmark announces recall of high blood pressure medication in US | ||
| 15.04. | Nxera and Handok partner for PIVLAZ supply in South Korea | ||
| 15.04. | Nigeria launches new 5-in-1 meningitis vaccine | ||
| 15.04. | SAHPRA recalls two Kenvue cough syrup batches | ||
| 12.04. | FDA approves new administration routes for Xcopri | ||
| 12.04. | Candel wins FDA orphan drug designation for pancreatic cancer drug | ||
| 12.04. | Century secures $60m in stock sale and buys preclinical cell therapy biotech | ||
| 12.04. | Fujifilm invests $1.2bn ramping up North Carolina facility | ||
| 12.04. | Moderna pauses plans to build mRNA facility in Kenya | ||
| 12.04. | Eliem Therapeutics agrees to acquire Tenet | ||
| 12.04. | Novartis signs deal for Arvinas' prostate cancer therapy | ||
| 12.04. | FDA approves AstraZeneca's FASENRA for asthma in children | ||
| 11.04. | UK's NICE recommends AbbVie's Aquipta to treat migraines | ||
| 11.04. | Pharmaceutical filtration and purification solutions for the pharmaceutical industry | ||
| 11.04. | Vertex joins pharma immunotherapy deal uptick with $4.9bn Alpine purchase |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
